Evidence map›Paper›PMID 37710334›Full record

ArticleSystematic reviews2023

The Commercial Determinants of Health and Evidence Synthesis (CODES): methodological guidance for systematic reviews and other evidence syntheses.

Mark Petticrew, Rebecca E Glover, Jimmy Volmink, Laurence Blanchard, Éadaoin Cott, Cécile Knai, Nason Maani, James Thomas, Alice Tompson, May C I van Schalkwyk and 1 more

Abstract read
In one paragraph

Article in Systematic reviews, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. The Effectiveness of Partnerships With Commercial Actors to Improve Food Environments: A Systematic Review.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mark PetticrewFaculty of Public Health and Policy, LSHTM, London, WC1H 9SH, UK. mark.petticrew@lshtm.ac.uk.ORCID http://orcid.org/0000-0002-6378-5517
Rebecca E GloverFaculty of Public Health and Policy, LSHTM, London, WC1H 9SH, UK.
Jimmy VolminkDepartment of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa.
Laurence BlanchardFaculty of Public Health and Policy, LSHTM, London, WC1H 9SH, UK.
Éadaoin CottDept for Health, University of Bath, Bath, UK.
Cécile KnaiFaculty of Public Health and Policy, LSHTM, London, WC1H 9SH, UK.
Nason MaaniGlobal Health Policy Unit, School of Social and Political Science, University of Edinburgh, Edinburgh, EH8 9LD, UK.
James ThomasUCL Institute of Education, University College London, 20 Bedford Way, London, WC1H 0AL, UK.
Alice TompsonFaculty of Public Health and Policy, LSHTM, London, WC1H 9SH, UK.
May C I van SchalkwykFaculty of Public Health and Policy, LSHTM, London, WC1H 9SH, UK.
Vivian WelchBruyère Research Institute, University of Ottawa, Ottawa, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe field of the commercial determinants of health (CDOH) refers to the commercial products, pathways and practices that may affect health. The field is growing rapidly, as evidenced by the WHO programme on the economic and commercial determinants of health and a rise in researcher and funder interest. Systematic reviews (SRs) and evidence synthesis more generally will be crucial tools in the evolution of CDOH as a field. Such reviews can draw on existing methodological guidance, though there are areas where existing methods are likely to differ, and there is no overarching guidance on the conduct of CDOH-focussed systematic reviews, or guidance on the specific methodological and conceptual challenges. METHODS/

resultsCODES provides guidance on the conduct of systematic reviews focussed on CDOH, from shaping the review question with input from stakeholders, to disseminating the review. Existing guidance was used to identify key stages and to provide a structure for the guidance. The writing group included experience in systematic reviews and other forms of evidence synthesis, and in equity and CDOH research (both primary research and systematic reviews).

conclusionsThis guidance highlights the special methodological and other considerations for CDOH reviews, including equity considerations, and pointers to areas for future methodological and guideline development. It should contribute to the reliability and utility of CDOH reviews and help stimulate the production of reviews in this growing field.

Indexed as

Quality of Health CareResearch PersonnelHumansReproducibility of ResultsSystematic Reviews as TopicCommercial determinants of healthFunding biasMethodsSystematic reviews

Identifiers

PMID37710334
PMCPMC10503085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.